Metabolic Associated Fatty Liver Disease Clinical Trials

23 clinical trials for Metabolic Associated Fatty Liver Disease across international registries, including 8 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Glucagon Resistance in Patients With MASLD and T2DM — RECRUITING · NA
• Efficacy and Safety of Rifaximin in Treating MAFLD — RECRUITING · PHASE1
• To Explore the Value of New MR Technology in Non-invasive Quantitative Assessment of Systemic Metabolism, Disease Status and Prognosis in Patients With Metabolic-Associated Fatty Liver Disease — RECRUITING
• Evaluation of Non-Invasive Tests for Metabolic Liver Disease — RECRUITING
• Effect of the Combined Application of Cynara Scolymus, Silybum Marianum, Curcuma Longa, and Glycyrrhiza Glabra in Improving Metabolic Associated Fatty Liver Disease : a Randomized Clinical Trial — RECRUITING · PHASE2
• Effect of Low Valine Diet on Body Weight and Metabolic Parameters — RECRUITING · NA
• Prevalence of MAFLD in Patients With Type 2 Diabetes in Jiangsu Province of China — RECRUITING
• A Prospective Cohort Study of Metabolic Associated Fatty Liver Disease in China — RECRUITING
• Analysis of Clinical Characteristics of Chronic Hepatitis B Combined With MAFLD in Different TCM Syndrome Types — COMPLETED
• Correlation Between Serum Nociceptin and Sympathetic Nerve Activity in Diabetic Patients With MAFLD — COMPLETED
• Metabolic Associated Fatty Liver Disease and Pancreatic Steatosis in Obese Versus Lean Chronic Hepatitis B Patients — COMPLETED
• Benefits of Trimetazidine in MASLD Patients — COMPLETED · PHASE2
• MAFLD Fibrosis Score for Detecting Fibrotic NASH in MAFLD Egyptian Patients — COMPLETED
• Therapeutic Response of Sodium-glucose Co-transporter Type-2 Inhibitor in Non-diabetic MAFLD Patients: a Pilot Study — ACTIVE_NOT_RECRUITING · PHASE4
• Characterization and Management of Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) — NOT_YET_RECRUITING · NA
• Clinical Characteristics of Metabolic Associated Fatty Liver Disease — OTHER
• Short Term Outcome of Metabolic Associated Fatty Liver Disease (MAFLD) in Patients Undergoing Bariatric Surgery — OTHER
• Evaluation of the Effectiveness of the Use of a Carnitine-Orotate Complex and Biphenyl Dimethyl Dicarboxylate in the Pathogenetic Therapy of Metabolic-associated Fatty Liver Disease: a Prospective Cohort Study — OTHER
• Supplementation With Alpha-lipoic Acid and Silybum Marianum(LUDLEV®) for the Improvement of Fatty Liver Disease — OTHER · NA
• Clinical Study of SARS-CoV-2 Vaccine in Metabolism-related Fatty Liver Disease — OTHER
• Effect of Empagliflozin and Dulaglutide on MAFLD in Patients With T2D — OTHER · PHASE4
• Lifestyle Modification for MAFLD Based on TTM — OTHER · NA
• MAFLD-simplified Definition as an Optimized Risk Stratification Tool for Predicting Metabolic Outcomes — COMPLETED

Refine this search